-Kiyoshi Takatsu Researcher Activity Profile

Research Author Detailed Information 

Kiyoshi Takatsu Publication Rate By Year

Kiyoshi Takatsu has published 1 paper(s) in 2006, 8 paper(s) in 2007, 7 paper(s) in 2008, for a total of 16 research publications in total.

Kiyoshi K Takatsu Author Information

LAST NAME: takatsu

FIRST NAME: kiyoshi

INITIALS: K

AFFILIATION:

Papers

Kiyoshi Takatsu's Publication Record

1. Crosstalk between neovessels and mural cells directs the site-specific expression of MT1-MMP to endothelial tip cells. Year Published: 2007
Division of Cancer Cell Research, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokane-dai, Minato-ku, Tokyo 108-8639, Japan.
2. Nasal cholera toxin elicits IL-5 and IL-5 receptor alpha-chain expressing B-1a B cells for innate mucosal IgA antibody responses. Year Published: 2007
Department of Pediatric Dentistry, Immunobiology Vaccine Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
3. The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages. Year Published: 2006
Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan.
4. A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses. Year Published: 2007
Division of Infectious Genetics, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo 108-8639, Japan.
5. Alteration of enzymatic properties of cell-surface antigen CD38 by agonistic anti-CD38 antibodies that prolong B cell survival and induce activation. Year Published: 2007
Department of Hard Tissue Engineering, Biochemistry, Division of Bio-Matrix, Graduate School, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo 113-8549, Japan.
6. A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses. Year Published: 2007
Division of Infectious Genetics, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo 108-8639, Japan.
7. Alteration of enzymatic properties of cell-surface antigen CD38 by agonistic anti-CD38 antibodies that prolong B cell survival and induce activation. Year Published: 2007
Department of Hard Tissue Engineering, Biochemistry, Division of Bio-Matrix, Graduate School, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo 113-8549, Japan. m.yokoyama.bch@tmd.ac.jp
8. CpG ODN mediated prevention from ovalbumin-induced anaphylaxis in mouse through B cell pathway. Year Published: 2008
Division of Immunology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
9. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. Year Published: 2008
Division of Infectious Diseases, Department of Medicine, New York University School of Medicine, New York, NY 10016, USA.
10. Alteration of enzymatic properties of cell-surface antigen CD38 by agonistic anti-CD38 antibodies that prolong B cell survival and induce activation. Year Published: 2007
Department of Hard Tissue Engineering, Biochemistry, Division of Bio-Matrix, Graduate School, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo 113-8549, Japan. m.yokoyama.bch@tmd.ac.jp
11. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. Year Published: 2008
Division of Infectious Diseases, Department of Medicine, 2Department of Pathology, and 3Department of Microbiology, New York University School of Medicine, New York, NY 10016.
12. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. Year Published: 2008
Division of Infectious Diseases, Department of Medicine, New York University School of Medicine, New York, NY 10016, USA.
13. Alteration of enzymatic properties of cell-surface antigen CD38 by agonistic anti-CD38 antibodies that prolong B cell survival and induce activation. Year Published: 2007
Department of Hard Tissue Engineering, Biochemistry, Division of Bio-Matrix, Graduate School, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo 113-8549, Japan. m.yokoyama.bch@tmd.ac.jp
14. Oct2 enhances antibody-secreting cell differentiation through regulation of IL-5 receptor {alpha} chain expression on activated B cells. Year Published: 2008
Immunology Division and 2Division of Cancer and Haematology, The Walter and Eliza Hall Institute, Parkville, Victoria 3050, Australia.
15. Oct2 enhances antibody-secreting cell differentiation through regulation of IL-5 receptor alpha chain expression on activated B cells. Year Published: 2008
Immunology Division, The Walter and Eliza Hall Institute, Parkville, Victoria 3050, Australia.
16. CpG ODN mediated prevention from ovalbumin-induced anaphylaxis in mouse through B cell pathway. Year Published: 2008
Division of Immunology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.